CAJ | 학술논문

目的：分析并评价我院2010-2012年颅内恶性肿瘤患者的用药情况。方法利用统计软件对我院神经外科2010-2012年的恶性肿瘤患者的用药种类、用药总量、销售价格等进行统计，并计算各种药物的DDC、DDDs以及B/A。结果颅内恶性肿瘤患者的用药种类广，几乎各类药均有使用，其中主要使用的药物包括抗感染药物(35.27%)、神经系统药物(16.48%)、心血管系统药物(11.83%)。结论颅内恶性肿瘤患者需要多种药物协同应用，其中抗感染药物占首位。我院对颅内恶性肿瘤患者的用药情况基本合理，在治疗中根据患者的个体差异，随时调整药物的种类和剂量，具体问题具体分析。
목적：분석병평개아원2010-2012년로내악성종류환자적용약정황。방법이용통계연건대아원신경외과2010-2012년적악성종류환자적용약충류、용약총량、소수개격등진행통계，병계산각충약물적DDC、DDDs이급B/A。결과로내악성종류환자적용약충류엄，궤호각류약균유사용，기중주요사용적약물포괄항감염약물(35.27%)、신경계통약물(16.48%)、심혈관계통약물(11.83%)。결론로내악성종류환자수요다충약물협동응용，기중항감염약물점수위。아원대로내악성종류환자적용약정황기본합리，재치료중근거환자적개체차이，수시조정약물적충류화제량，구체문제구체분석。
Objective To analyse and evaluate the usage of drugs for intracranial malignant tumor patients of our hospital from 2010 to 2012. Methods The kinds,dose,sales price of the drug in the malignant tumor patients from 2010 to 2012 in Department of neurosurgery in our hospital were statistically summarized by statistical software, and DDC, DDDs and B/A of various drugs were calculated. Results The drug species used in patients with malignant intracranial tumor were wide, almost all kinds of drugs were used, which mainly include the use of anti infective drugs(35.2%), nervous system drugs(16.48%), cardiovascular drugs(11.83%). Conclusion Intracranial malignant tumor patients need multiple drugs collaborative applications, in which anti-infection drugs account for the first. The use of drugs in our hospital of patients with intracranial malignant tumors is basically reasonable, according to the individual difference of the patient, the type and dose of drugs need to adjust at any time in the treatment, concrete problems need concrete analysis.